AUR-201

COMBINATION_PRODUCT3 trials

Sponsors

Auregen Biotherapeutics, SA

Conditions

Microtia

Phase 1

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

TerminatedNCT06072040

Auregen Biotherapeutics, SAMicrotia

Start: 2024-01-26End: 2025-11-14Updated: 2025-11-21

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201

TerminatedNCT06078566

Auregen Biotherapeutics, SAMicrotia

Start: 2024-01-26End: 2025-11-14Updated: 2025-11-21

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia)

TerminatedNCT06225336

Auregen Biotherapeutics, SAMicrotia

Start: 2022-11-04End: 2025-09-10Updated: 2025-11-19